Patients sue GLP-1 drugmakers over sudden vision loss risk
WSJ reports patients have filed lawsuits against GLP-1 drugmakers alleging risk of sudden vision loss, citing symptoms including blurred vision and reduced peripheral sight.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.